Twist1 Influences the Expression of Leading Members of the IL-17 Signaling Pathway in HER2-Positive Breast Cancer Cells
Breast cancer (BC) is a heterogeneous disease composed of multiple subtypes with different molecular characteristics and clinical outcomes. The metastatic process in BC depends on the transcription factors (TFs) related to epithelial-mesenchymal transition (EMT), including the master regulator Twist...
Main Authors: | Bruno R. B. Pires, Renata Binato, Gerson M. Ferreira, Stephany Corrêa, Bárbara Du Rocher, Daniel Bulzico, Susanne Crocamo, Everton Cruz dos Santos, Luize G. Lima, Eliana Abdelhay |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/22/12144 |
Similar Items
-
Translational Results of Zo-NAnTax: A Phase II Trial of Neoadjuvant Zoledronic Acid in HER2-Positive Breast Cancer
by: Susanne Crocamo, et al.
Published: (2022-12-01) -
A Reappraisal on the Potential Ability of Human Neutrophils to Express and Produce IL-17 Family Members In Vitro: Failure to Reproducibly Detect It
by: Nicola Tamassia, et al.
Published: (2018-04-01) -
The Emerging Role of the IL-17B/IL-17RB Pathway in Cancer
by: Jérémy Bastid, et al.
Published: (2020-04-01) -
IL-17C/IL-17RE: Emergence of a Unique Axis in TH17 Biology
by: Jasper F. Nies, et al.
Published: (2020-02-01) -
Characterization of the IL-17 and CD4+ Th17 Cells in the Clinical Course of Dengue Virus Infections
by: Luis Alberto Sánchez-Vargas, et al.
Published: (2020-12-01)